StockWatch
·
Pharmaceuticals
Subsidiary15 Oct 2026, 06:10 pm

Trident Mediquip Private Placement Reduces Parent Stake to 58.23%

AI Summary

Trident Lifeline Ltd announced that its subsidiary, Trident Mediquip Limited (TML), has completed a private placement of equity shares. Following this placement, Trident Lifeline's shareholding in TML has decreased from 59.67% to 58.23%. TML operates in the Medical Device Industry and reported a turnover of ₹27.31 Cr for FY26. The transaction is considered a related party transaction as TML is a subsidiary, but it is being conducted on an arm's length basis. No specific acquisition cost or consideration details were provided as the transaction relates to a subsidiary's internal share allotment.

Key Highlights

  • Trident Mediquip Ltd completed a private placement of equity shares.
  • Trident Lifeline's stake in subsidiary TML reduced to 58.23%.
  • TML is in the Medical Device Industry with FY26 turnover of ₹27.31 Cr.
  • Transaction is on an arm's length basis despite being a related party.